Media
News
Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.
9 - 16of about 61 News
9 - 16of about 61 News






Bayer extends clinical development program for finerenone with Phase II study investigating the initial combination therapy with empagliflozin in patients with chronic kidney disease and type 2 diabetes

Rural-based charities a little richer with the help of Canadian farmers and the Bayer Fund’s Canada’s Farmers Grow Communities Program

The American Society of Nephrology (ASN)’s Kidney Week 2021:
New analyses of the comprehensive finerenone clinical trial program reinforces renal and cardiovascular benefits in patients with CKD and T2D, independent of baseline therapy
9 - 16of about 61 News
9 - 16of about 61 News
Contact us:
Communications Department
Email: mediacanada@bayer.com